Bi-Specific MAbS Market Industry Trends And Emerging Opportunities Till 2030

1
Bi-Specific MAbS Market Global Report 2020-30
Covid 19 Growth And Change
2
Bi-Specific MAbS Market
Characteristics

• The global bi-specific MAbs market was valued at
  about 1.56 billion in 2019 and is expected to
  grow to 2.93 billion in 2020 at a compound
  annual growth rate (CAGR) of 87.6. The COVID-19
  restrictions caused a slowdown in growth from
  2018 due to missed patient visits affecting
  potential new patients who deferred the care,
  whereas existing patients remained on their
  treatment. However, with the sales beginning to
  recover slowly, the market is expected to
  stabilize and reach 6.12 billion by 2023 at a
  CAGR of 27.8.
• The Business Research Company published its
  Bi-Specific MAbS Global Market Report 2020 which
  provides strategists, marketers and senior
  management with the critical information they
  need to assess the global Bi-Specific MAbS
  market. The report provides in-depth analysis of
  the impact of COVID-19 on the market, along with
  revised market numbers due to the effects of the
  coronavirus.
• The report covers the Bi-Specific MAbS markets
  segments-
• 1) By Type Catumaxomab (Removab), Blinatumomab,
  Duligotumab, SAR 156597
• 2) By Product Type In Vivo, In Vitro
• The major regions included in the report are
  Asia-Pacific, Western Europe, Eastern Europe,
  North America, South America, Middle East, and
  Africa.

Click Here To View Complete Report
3
Major Key PlayersJohnson Johnson,
Novartis AG, Hoffmann-La Roche Ltd., Novo
Nordisk A/S, Bayer AG, Thermo Fisher
Scientific, Inc., Bistro-Myers Squibb.
Click Here To Get A Sample Report
4
Table Of Content

• 1. Executive Summary
• 2. Report Structure
• 3. Bi-Specific MAbS Market Characteristics
• 4. Bi-Specific MAbS Market Product Analysis
• 5. Bi-Specific MAbS Market Supply Chain
• 26. Key Mergers And Acquisitions In The
  Bi-Specific MAbS Market
• 27. Bi-Specific MAbS Market Trends And Strategies
• 28. Bi-Specific MAbS Market Future Outlook and
  Potential Analysis
• 29. Appendix
• Click Here To Get A Sample Report

5
Get In Touch
Whatever your need be, at The Business Research
Company we provide research consulting solutions
for businesses, government agencies
consultancies, and market research companies.
6
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE. 44 207 1930
708 Email info_at_tbrc.info www.tbrc.info
Asia The Business Research Company, Horizon
Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara
Hills Hyderabad (India) 500033 91
8897263534 Email info_at_tbrc.info www.tbrc.info
Americas The Business Research Company 625 South
Avenue, Apt B204, Secane, Philadelphia, PA 19018,
USA 1 3156230293 Email info_at_tbrc.info www.tbrc.
info